Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Salvetti

Showing results (1-10 of 231) with videos related to

Pageof 24
Sort By:
The Lancet. Neurology|March 19, 2022
Epstein-Barr virus and multiple sclerosis: supporting causalityFrancesca Aloisi, Marco Salvetti
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 11, 2024
EBV infection drives MS pathology: YesFrancesca Aloisi, Marco Salvetti
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 19, 2019
Brain fibrinogen deposition plays a key role in MS pathophysiology - CommentaryTatiana Koudriavtseva, Marco Salvetti
Nature|July 20, 2018
Evaluation woes: define metrics from the offPaola Zaratin, Marco Salvetti
JAMA Neurology|May 12, 2015
Association between vaccines and neuroinflammation: time, risks, and benefitsGiovanni Ristori, Rosella Mechelli, Marco Salvetti
Experimental Neurology|December 11, 2012
The mood-immunity relationship in multiple sclerosisGiovanni Ristori, Viviana Annibali, Marco Salvetti
Current Opinion in Neurology|April 11, 2009
Epstein-Barr virus and multiple sclerosisMarco Salvetti, Gavin Giovannoni, Francesca Aloisi
The Lancet. Neurology|February 10, 2023
Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapyFrancesca Aloisi, Gavin Giovannoni, Marco Salvetti
Frontiers in Neurology|January 30, 2019
A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic EncephalomyelitisDomenico Plantone, Matilde Inglese, Marco Salvetti, et al.
Frontiers in Neurology|April 6, 2019
Corrigendum: A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic EncephalomyelitisDomenico Plantone, Matilde Inglese, Marco Salvetti, et al.
Pageof 24

Showing results (1-10 of 231) with videos related to

Sort By:
Pageof 24
The Lancet. Neurology|March 19, 2022
Epstein-Barr virus and multiple sclerosis: supporting causalityFrancesca Aloisi, Marco Salvetti
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 11, 2024
EBV infection drives MS pathology: YesFrancesca Aloisi, Marco Salvetti
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 19, 2019
Brain fibrinogen deposition plays a key role in MS pathophysiology - CommentaryTatiana Koudriavtseva, Marco Salvetti
Nature|July 20, 2018
Evaluation woes: define metrics from the offPaola Zaratin, Marco Salvetti
JAMA Neurology|May 12, 2015
Association between vaccines and neuroinflammation: time, risks, and benefitsGiovanni Ristori, Rosella Mechelli, Marco Salvetti
Experimental Neurology|December 11, 2012
The mood-immunity relationship in multiple sclerosisGiovanni Ristori, Viviana Annibali, Marco Salvetti
Current Opinion in Neurology|April 11, 2009
Epstein-Barr virus and multiple sclerosisMarco Salvetti, Gavin Giovannoni, Francesca Aloisi
The Lancet. Neurology|February 10, 2023
Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapyFrancesca Aloisi, Gavin Giovannoni, Marco Salvetti
Frontiers in Neurology|January 30, 2019
A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic EncephalomyelitisDomenico Plantone, Matilde Inglese, Marco Salvetti, et al.
Frontiers in Neurology|April 6, 2019
Corrigendum: A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic EncephalomyelitisDomenico Plantone, Matilde Inglese, Marco Salvetti, et al.
Pageof 24